Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Retinopathy is not the only ocular symptom: myasthenia gravis in association with interferon therapy.

Literature DB >> 16234478

Retinopathy is not the only ocular symptom: myasthenia gravis in association with interferon therapy.

A Oishi, K Miyamoto, S Kashii, N Yoshimura.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2005 PMID： 16234478 PMCID： PMC1772937 DOI： 10.1136/bjo.2005.077537

Source DB: PubMed Journal: Br J Ophthalmol ISSN： 0007-1161 Impact factor: 4.638

× No keyword cloud information.

6 in total

1. Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin.

Authors: C J Weegink; R A Chamuleau; H W Reesink; D S Molenaar
Journal: J Gastroenterol Date: 2001-10 Impact factor: 7.527

2. Exacerbation of myasthenia gravis in a patient after interferon-beta treatment for chronic active hepatitis C.

Authors: H Harada; A Tamaoka; Y Kohno; A Mochizuki; S Shoji
Journal: J Neurol Sci Date: 1999-06-01 Impact factor: 3.181

3. Development of myasthenia gravis after interferon alpha therapy.

Authors: I G Gurtubay; G Morales; O Aréchaga; J Gállego
Journal: Electromyogr Clin Neurophysiol Date: 1999-03

Review 4. Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis.

Authors: F L Dumoulin; L Leifeld; T Sauerbruch; U Spengler
Journal: Biomed Pharmacother Date: 1999-06 Impact factor: 6.529

5. Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C.

Authors: G Borgia; L Reynaud; I Gentile; R Cerini; R Ciampi; M Dello Russo; M Piazza
Journal: J Interferon Cytokine Res Date: 2001-07 Impact factor: 2.607

Review 6. [A case of myasthenia gravis which developed myasthenic crisis after alpha-interferon therapy for chronic hepatitis C].

Authors: T Konishi
Journal: Rinsho Shinkeigaku Date: 1996-08

6 in total

4 in total

Retinopathy is not the only ocular symptom: myasthenia gravis in association with interferon therapy.

1. Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin.

2. Exacerbation of myasthenia gravis in a patient after interferon-beta treatment for chronic active hepatitis C.

3. Development of myasthenia gravis after interferon alpha therapy.

Review 4. Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis.

5. Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C.

Review 6. [A case of myasthenia gravis which developed myasthenic crisis after alpha-interferon therapy for chronic hepatitis C].

1. Abducens palsy and Sjogren's syndrome induced by pegylated interferon therapy.

Review 2. Ophthalmologic complications of antiviral therapy in hepatitis C treatment.

Review 3. Ocular side effects of biological agents in oncology: what should the clinician be aware of?

Review 4. Safety, Tolerability, and Immunogenicity of Interferons.